Financial Instruments - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Investments [Line Items]
Cash, cash equivalents and short -term investments	$ 114,600,000	$ 141,000,000.0
Impairment charges related to marketable debt securities	0
Provision for credit loss expense related available for sale debt securities	0	0
Operating Accounts
Schedule Of Investments [Line Items]
Cash, cash equivalents and short -term investments	$ 81,500,000	$ 38,600,000